ISPOR - PCV8 Cost-Utility and Budget IMPACT Analysis of Using Ranolazine in the Treatment of Refractory Stable Angina, an Iranian Heath System Perspective

PCV8 Cost-Utility and Budget IMPACT Analysis of Using Ranolazine in the Treatment of Refractory Stable Angina, an Iranian Heath System Perspective

Abstract

Authors

S. Nikfar R. Ghanavati M.M. Ashrafian rahaghi M. Zargaran

Full Text Cite This Article

Back to Volume 22, Supplemental S

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now